Cinqair (Reslizumab) Infusions

Cinqair belongs to a class of drugs known as monoclonal antibodies. It works by reducing swelling of the airways in the lungs to make breathing easier. Generically known as reslizumab, Cinqair can be administered via injectable therapy.

Cinqair infusions and reslizumab injectable treatments are used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma.

Drug manufacturer information for Cinqair is available here.